158 related articles for article (PubMed ID: 308614)
1. Systemic membrane defect in the proximal muscular dystrophies.
Pickard NA; Gruemer HD; Verrill HL; Isaacs ER; Robinow M; Nance WE; Myers EC; Goldsmith B
N Engl J Med; 1978 Oct; 299(16):841-6. PubMed ID: 308614
[TBL] [Abstract][Full Text] [Related]
2. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte capping in limb-girdle muscular dystrophy: patients and carriers in an Amish isolate.
Bader PI; Bender CJ; Creason MT; Conn PS; Townsend DW
Am J Med Genet; 1982 Jul; 12(3):255-69. PubMed ID: 7114089
[No Abstract] [Full Text] [Related]
4. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
[TBL] [Abstract][Full Text] [Related]
5. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
[TBL] [Abstract][Full Text] [Related]
6. Human lymphocyte capping and the effect of lanthanum in Duchenne muscular dystrophy.
Horenstein AL; Emery AE
Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):303-12. PubMed ID: 6635321
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte capping in limb-girdle muscular dystrophy.
Sybert VP
Am J Med Genet; 1983 May; 15(1):181-3. PubMed ID: 6859123
[No Abstract] [Full Text] [Related]
8. Dystrophin assay in muscular dystrophies: an Indian experience.
Jain S; Sarkar C; Dinda AK; Maheshwari MC
Natl Med J India; 1993; 6(6):259-62. PubMed ID: 7950930
[TBL] [Abstract][Full Text] [Related]
9. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
[TBL] [Abstract][Full Text] [Related]
10. Sporadic Duchenne muscular dystrophy in females; genetic counseling of women with pelvifemoral muscular dystrophy.
Zellweger H; Ionasescu V; Simpson J
Helv Paediatr Acta; 1980 Sep; 35(4):343-8. PubMed ID: 7451237
[TBL] [Abstract][Full Text] [Related]
11. Application of DNA probes to carrier detection and prenatal diagnosis of Duchenne (and Becker) muscular dystrophy.
Mulley JC; Gedeon AK; Haan EA; Sheffield LJ; White SJ; Bates LJ; Robertson EF; Sutherland GR
Aust Paediatr J; 1988; 24 Suppl 1():92-7. PubMed ID: 3202740
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte capping in carriers of Duchenne muscular dystrophy.
Bader PI
N Engl J Med; 1979 Sep; 301(13):725. PubMed ID: 481472
[No Abstract] [Full Text] [Related]
13. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
[TBL] [Abstract][Full Text] [Related]
14. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales.
Norman A; Harper P
Clin Genet; 1989 Jul; 36(1):31-7. PubMed ID: 2766561
[TBL] [Abstract][Full Text] [Related]
15. The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females.
Zatz M; Marie SK; Cerqueira A; Vainzof M; Pavanello RC; Passos-Bueno MR
Am J Med Genet; 1998 May; 77(2):155-61. PubMed ID: 9605290
[TBL] [Abstract][Full Text] [Related]
16. Potential pitfalls in using DNA probes to counsel Duchenne and Becker muscular dystrophy families.
Shi YJ; Fischbeck KH; Ritter A
Chin Med J (Engl); 1992 Jun; 105(6):469-75. PubMed ID: 1451547
[TBL] [Abstract][Full Text] [Related]
17. [In vitro study of fibroblasts from patients with Duchenne muscular dystrophy. Evaluation of capping and ultrastructural aspect].
Charbonné F; Perissel B; Boué A; Normand B; Mage G; Vanneuville G; Turchini JP; Malet P
Pathol Biol (Paris); 1985 Sep; 33(7):751-7. PubMed ID: 3909073
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte capping in Duchenne muscular dystrophy.
Pickard NA; Gruemer HD; Nance WE; Goldsmith BM
Lancet; 1979 Aug; 2(8137):306. PubMed ID: 88637
[No Abstract] [Full Text] [Related]
19. Lymphocyte capping and carrier detection in Duchenne muscular dystrophy.
Sands ME; Harris R
Lancet; 1979 Sep; 2(8144):698. PubMed ID: 90790
[No Abstract] [Full Text] [Related]
20. Carrier detection by microsatellite analysis of Duchenne/Becker muscular dystrophy in Hungarian families.
Bachrati CZ; Somodi Z; Endreffy E; Kalmár T; Raskó I
Ann Hum Genet; 1998 Nov; 62(Pt 6):511-20. PubMed ID: 10363129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
